US20120283668A1 - Apparatus and method for using effervescent tablets for cosmetic care - Google Patents
Apparatus and method for using effervescent tablets for cosmetic care Download PDFInfo
- Publication number
- US20120283668A1 US20120283668A1 US13/171,713 US201113171713A US2012283668A1 US 20120283668 A1 US20120283668 A1 US 20120283668A1 US 201113171713 A US201113171713 A US 201113171713A US 2012283668 A1 US2012283668 A1 US 2012283668A1
- Authority
- US
- United States
- Prior art keywords
- active material
- tablet
- skin
- chemical reaction
- granules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 25
- 239000002537 cosmetic Substances 0.000 title claims abstract description 23
- 239000007938 effervescent tablet Substances 0.000 title description 18
- 238000011282 treatment Methods 0.000 claims abstract description 59
- 239000000463 material Substances 0.000 claims abstract description 43
- 239000011149 active material Substances 0.000 claims abstract description 31
- 238000006243 chemical reaction Methods 0.000 claims abstract description 31
- 239000008187 granular material Substances 0.000 claims abstract description 31
- 239000007787 solid Substances 0.000 claims abstract description 29
- 230000000694 effects Effects 0.000 claims description 32
- 239000007788 liquid Substances 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 19
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 11
- 239000001569 carbon dioxide Substances 0.000 claims description 10
- 239000007791 liquid phase Substances 0.000 claims 1
- 239000007790 solid phase Substances 0.000 claims 1
- 230000004913 activation Effects 0.000 abstract description 3
- 238000007670 refining Methods 0.000 abstract description 2
- 239000003826 tablet Substances 0.000 description 99
- 210000003491 skin Anatomy 0.000 description 76
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 37
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 37
- 239000000499 gel Substances 0.000 description 32
- 239000000203 mixture Substances 0.000 description 19
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 18
- 239000000314 lubricant Substances 0.000 description 17
- 239000011230 binding agent Substances 0.000 description 16
- 235000017557 sodium bicarbonate Nutrition 0.000 description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 14
- 239000002585 base Substances 0.000 description 14
- 239000011975 tartaric acid Substances 0.000 description 14
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 13
- 239000002253 acid Substances 0.000 description 13
- 235000002906 tartaric acid Nutrition 0.000 description 13
- 229960004106 citric acid Drugs 0.000 description 11
- 235000015165 citric acid Nutrition 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 11
- 239000000654 additive Substances 0.000 description 10
- 239000000843 powder Substances 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 7
- 235000015497 potassium bicarbonate Nutrition 0.000 description 7
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 6
- 238000004090 dissolution Methods 0.000 description 6
- 239000006260 foam Substances 0.000 description 6
- 229940100688 oral solution Drugs 0.000 description 6
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 6
- 239000011736 potassium bicarbonate Substances 0.000 description 6
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 5
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 5
- 229960002303 citric acid monohydrate Drugs 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000000945 filler Substances 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- -1 polytetrafluorethylene Polymers 0.000 description 5
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical class [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000003974 emollient agent Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 238000005461 lubrication Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 238000005192 partition Methods 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000007916 tablet composition Substances 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- 238000009736 wetting Methods 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 230000003255 anti-acne Effects 0.000 description 3
- 239000002518 antifoaming agent Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000000845 maltitol Substances 0.000 description 3
- 235000010449 maltitol Nutrition 0.000 description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 3
- 229940035436 maltitol Drugs 0.000 description 3
- 239000013081 microcrystal Substances 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000001103 potassium chloride Substances 0.000 description 3
- 235000011164 potassium chloride Nutrition 0.000 description 3
- 238000005201 scrubbing Methods 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- 230000037331 wrinkle reduction Effects 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Chemical compound CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 2
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229960003121 arginine Drugs 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000005587 bubbling Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000007907 direct compression Methods 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 229910001651 emery Inorganic materials 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000007897 gelcap Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 235000001055 magnesium Nutrition 0.000 description 2
- 239000000395 magnesium oxide Substances 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- 235000012245 magnesium oxide Nutrition 0.000 description 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 239000003232 water-soluble binding agent Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 1
- NMUKKQFFBNEVJY-UHFFFAOYSA-K 4-O-bis[(4-oct-1-enoxy-4-oxobutanoyl)oxy]alumanyl 1-O-oct-1-enyl butanedioate Chemical compound [Al+3].CCCCCCC=COC(=O)CCC([O-])=O.CCCCCCC=COC(=O)CCC([O-])=O.CCCCCCC=COC(=O)CCC([O-])=O NMUKKQFFBNEVJY-UHFFFAOYSA-K 0.000 description 1
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000001904 Arabinogalactan Substances 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N C Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- PATIOEOWLCYRRS-UHFFFAOYSA-N C.CC#CCOOOOOO.[HH] Chemical compound C.CC#CCOOOOOO.[HH] PATIOEOWLCYRRS-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical class [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003911 antiadherent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229940038481 bee pollen Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000008275 binding mechanism Effects 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- OCHFNTLZOZPXFE-JEDNCBNOSA-N carbonic acid;(2s)-2,6-diaminohexanoic acid Chemical compound OC(O)=O.NCCCC[C@H](N)C(O)=O OCHFNTLZOZPXFE-JEDNCBNOSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- RRPFCKLVOUENJB-UHFFFAOYSA-L disodium;2-aminoacetic acid;carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O.NCC(O)=O RRPFCKLVOUENJB-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000008384 inner phase Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 229940037627 magnesium lauryl sulfate Drugs 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Substances [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- HBNDBUATLJAUQM-UHFFFAOYSA-L magnesium;dodecyl sulfate Chemical compound [Mg+2].CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCOS([O-])(=O)=O HBNDBUATLJAUQM-UHFFFAOYSA-L 0.000 description 1
- ZADYMNAVLSWLEQ-UHFFFAOYSA-N magnesium;oxygen(2-);silicon(4+) Chemical compound [O-2].[O-2].[O-2].[Mg+2].[Si+4] ZADYMNAVLSWLEQ-UHFFFAOYSA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229940016409 methylsulfonylmethane Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 239000008385 outer phase Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 238000005549 size reduction Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910000031 sodium sesquicarbonate Inorganic materials 0.000 description 1
- 235000018341 sodium sesquicarbonate Nutrition 0.000 description 1
- 229940045902 sodium stearyl fumarate Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 229940117960 vanillin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229940118827 zinc phenolsulfonate Drugs 0.000 description 1
- BOVNWDGXGNVNQD-UHFFFAOYSA-L zinc;2-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=CC=C1S([O-])(=O)=O.OC1=CC=CC=C1S([O-])(=O)=O BOVNWDGXGNVNQD-UHFFFAOYSA-L 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D34/00—Containers or accessories specially adapted for handling liquid toiletry or cosmetic substances, e.g. perfumes
- A45D34/04—Appliances specially adapted for applying liquid, e.g. using roller or ball
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
- A61K8/0225—Granulated powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D2200/00—Details not otherwise provided for in A45D
- A45D2200/05—Details of containers
- A45D2200/058—Means for mixing different substances prior to application
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D2200/00—Details not otherwise provided for in A45D
- A45D2200/10—Details of applicators
- A45D2200/1009—Applicators comprising a pad, tissue, sponge, or the like
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D2200/00—Details not otherwise provided for in A45D
- A45D2200/10—Details of applicators
- A45D2200/1009—Applicators comprising a pad, tissue, sponge, or the like
- A45D2200/1036—Applicators comprising a pad, tissue, sponge, or the like containing a cosmetic substance, e.g. impregnated with liquid or containing a soluble solid substance
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D2200/00—Details not otherwise provided for in A45D
- A45D2200/10—Details of applicators
- A45D2200/1054—Abrasive cosmetic skin peeling or scrubbing
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D44/00—Other cosmetic or toiletry articles, e.g. for hairdressers' rooms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
- A61K2800/222—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
- A61K2800/882—Mixing prior to application
Definitions
- the present invention relates to method and apparatus for applying cosmetic treatment to skin and more particular, method for applying cosmetic treatment to skin using effervescent chemical composition and to apparatus for applying such treatment.
- Facial skin cleaning, brightening or rejuvenating by chemical treatment, laser treatment or by exfoliation using machine driven means are known in the art. Such methods typically require medical supervision and involve some risk of damaging side effects, pain and discomfort during treatment. These methods typically require long recovery time between treatments.
- creams comprising granules (or microcrystals), such as of alumina, which are applied to the outer layers of the skin using mechanical means such as a vibrator. These methods achieve limited level of penetration of the resurfacing microcrystals into the treated skin and suffer of a fix level of skin cells removal as dictated by the size of the microcrystals throughout the treatment.
- Method and means for skin treatment that provide high level of penetration of the treating material into the skin, that gradually lowers the level of skin cell removal throughout the treatment to provide improved final level of skin smoothness and that may be safely applied, preferably by the person himself, with no pains or recovery time, are desired.
- the desired method and means should be inexpensive and easily achievable, virtually anywhere.
- FIG. 1 is a flow diagram illustrating method of applying cosmetic skin treatment, according to embodiments of the present invention
- FIGS. 1A , 1 B, 1 C, and 1 D show apparatuses for holding a shaped tablet according to embodiments of the present invention
- FIGS. 2A and 2B show apparatuses for holding a shaped tablet according to embodiments of the present invention
- FIGS. 3A and 3B depict applicators for holding a shaped tablet according to embodiments of the present invention
- FIGS. 4A , 4 B and 4 C and FIGS. 5A and 5B show liquid containers and tablet holders according to embodiments of the present invention
- FIGS. 6A , 6 B, 6 C and 6 D show various shapes of capsule tablets according to embodiments of the present invention
- FIGS. 7A and 7B show various forms of a squirter apparatus comprising capsule shaped tablet according to embodiments of the present invention
- FIGS. 8A and 8B show a squirter similar to the squirter of FIGS. 7A and 7B featuring a rotation and vibration movements applicable to a tablet of the present invention
- FIGS. 9A and 9B show mouth hygiene apparatuses comprising a tablet according to embodiments of the present invention.
- FIGS. 10A , 10 B and 10 C show handheld evaporative humidifier apparatuses comprising each a tablet according to embodiments of the present invention
- FIGS. 11A , 11 B and 11 C depict skin treatment tool adapted to operate with skin treatment tablet according to embodiments of the present invention, in side view, bottom view and blown view, respectively;
- FIGS. 12 , 12 A and 12 B depict a blow-up view of skin treatment tool 1200 , a partial sectional view of treatment tool 1202 and a top view of mediator 1206 , respectively, according to embodiments of the present invention.
- Skin treatment in general and cosmetic skin treatment more particularly employ a variety of means and materials aimed to serve a variety of targets, such as removal of the epidermal layer (upper/outer layer) of the skin, lightening the skin color, applying of aromatic or moisturizing materials, applying medical compositions, vitamins or disinfectants, etc.
- Such treatment means and materials as known in the art are typically expensive and have limited effect due to their limited ability to penetrate into, or through the upper-most outer layer of the epidermal skin layer.
- the well known phenomena of the effervescence effect of the chemical reaction of certain first and second materials, such as baking soda (sodium bicarbonate) with certain other materials, such as citric acid (C 6 H 8 O 7(aq) may be utilized in cosmetic skin treatment to achieve improved treatment results with respect to the depth of removed epidermis layer, the level of penetration of treating materials into the skin and the final smoothness of the treated skin at the end of the treatment.
- the first material may be a base with low value of pH, for example lower than 7 and the second material may be acidic with high value of pH, for example higher than 7.
- the chemical reaction of baking soda with citric acid is defined by:
- This phenomenon may be utilized, according to embodiments of the present invention, by using the gas that is released during the reaction (e.g. CO 2 ) to push and force the treating material granules into the treated skin, deeper than is possible without the assistance of the released gas.
- the treating material may be, according to embodiments of the present invention, merely the granules of the first active material, e.g. baking soda or sodium bicarbonate.
- the treating material may also contain granules of one or more of materials produced during the chemical reaction. These granules may act on the skin like an emery paper when buffed into the treated skin.
- the treating reacting material or materials may be buffed into the skin using one or more of the various means presented and described in details below.
- first and/or second materials may be provided in any adequate phase, e.g. solid, powder, liquid, gel or gas—as long as their chemical reaction will provide granules and gas.
- at least one of the first and second active materials may be provided in liquid form (e.g. dissolved in water or the like) or dissolved in gel.
- the liquid or gel in which one of the active materials is dissolved may be used, according to embodiments of the present invention as a wetting, gliding or oiling material to provide smoother gliding of an apparatus of the present invention with treated skin.
- the carrying liquid and/or gel may be used to provide treating materials to the treated skin.
- the chemical features of such carrying liquid or gel may be selected as may be desired, e.g. to have no effect on the chemical reaction, to release one or more product materials that has positive effect on the treated skin, as may be required, etc.
- the continuing decrease in the size of the granules of the reacting first material may be utilized for continuous refining of the level of epidermis removal, resulting in refined smoothness of the skin at the end of the treatment. This may last as long as the emery paper effect of the particles is effective for removal and/or smoothing the treated skin.
- the initial size of the granules of the first material may be selected for treatment with a defined level of initial skin removal capacity and the rate of granules size reduction may be controlled to fit the specific treatment needs. It will be appreciated by a person skilled in the art that other solutions may also be used according to embodiments of the present invention which, when reacting, act on the granules of at least one active material to reduce their size during the reaction.
- the treating materials may be provided in the form of a tablet that may have defined from, that may contain the required materials for achieving the required treatment goals and that may be applied to the treated skin during the treatment using specially designed apparatuses, as is described in details herein below.
- tablette as used throughout this specification, relates to material or materials that are adapted to participate in a chemical reaction and that are provided in a solid form, having a defined shape, where not all of the materials contained in the tablet necessarily adapted to participate in that chemical reaction.
- tablets made according to embodiments of the invention may comprise, additionally to the first and second active materials, materials for treating the skin, for lightening its color, for providing odors, for providing vitamins, for casing exothermic effect, etc.
- the amount of each of the ingredients in a tablet, as well as their order of release, their level of solubility and other respective features may be set so as to fulfill the treatment goals it is designed for, as is explained in details below.
- the described tablets are made for dissolving in the bath water and are made of several layers of the desired materials so that the release of each layer, in its turn, into the bath water, provides different user experience.
- US 2008/0146487 does not disclose or suggest direct application of the tablets on a human's skin for achieving cosmetic treatment effects, nor does it disclose use of the effervescence effect for enhancing the cosmetic treatment effect or reliance on the lessening size of granules of material in the tablet for controlling the cosmetic treatment effect so as to refine the final smoothness of the skin.
- effects of materials included in the tablets described in US 2008/0146487 on the user's skin are limited to the exposure of the skin to their presence next to the user's body, after the tablet is dissolved in the amount of bath water, typically tens of liters or more.
- use of exothermic ingredients in the tablets disclosed in US 2008/0146487 is expected to have very limited experience effect for a bathing user when this ingredient is dissolved in tens of mild temperature liters of water.
- the choice of ingredients for effervescent granules may be deducted both by the requirement of the manufacturing process and the necessity of making a preparation which dissolves in water.
- the required ingredients are at least one acid and at least one base.
- the base should release, according to embodiments of the present invention, carbon dioxide upon reaction with the acid.
- acids may include tartaric acid and citric acid.
- bases include sodium carbonate, potassium bicarbonate, sodium bicarbonate.
- Effervescent granules may usually be prepared from a combination of citric and tartaric acid rather than from a single acid because the use of either acid alone may cause difficulties. When tartaric acid is the sole acid, the resulting granules readily crumble and lack mechanical strength.
- Citric acid alone may result in a sticky mixture which is difficult to granulate during the manufacturing process.
- Effervescent salts may include the following ingredients, which may actually produce the effervescence: sodium bicarbonate, citric acid and tartaric acid. When added to water the acids and base may react to liberate carbon dioxide, resulting in effervescence. It should be noted that any acid-base combination which results in the liberation of carbon dioxide could be used in place of this combination as long as the ingredients are suitable for pharmaceutical use.
- USP 24 includes the following seven monographs, that may be used for tablets according to embodiments of the present invention:
- a perfect lubricant for effervescent products must be nontoxic and water-soluble. Very few traditional lubricants fulfill these requirements. Intrinsic lubricants are added to the powder mixture and consequently included in the formulation. When added in solid form, the lubricant will have to be finely divided. Metal stearates, such as magnesium or calcium stearate that serve as lubricants in conventional tablets, are seldom used as intrinsic lubricants in connection with effervescent tablets due to their insolubility in water. Use of stearates results in an undissolved, foamy, soapy-tasting layer on the surface of the cloudy solution. In addition, normal lubricant concentrations of metal stearates make the tablets hydrophobic, which entails a slow dissolution of the effervescent tablet in the water.
- metal stearates can be used to improve the rate of solution of effervescent tablets as the tablet will remain immersed in the water during dissolution and not float to the surface the way a tablet without metal stearate would.
- a floating tablet presents a smaller surface area to the water than a tablet immersed in the liquid.
- Sodium stearate and sodium oleate are water-soluble in low concentrations. They have the characteristic soapy taste, which virtually precludes their use in oral effervescent products but can be used for topical applications.
- a combination of 4% polyethylene glycol (PEG) 6000 and 0.1% sodium stearyl fumarate proved to be a good lubricant for ascorbic acid tablets made by direct compression on a small scale.
- Sodium chloride, sodium acetate, and D,L-leucine also have been suggested for effervescent tablets.
- the lubricant used in effervescent formulations should combine hydrophobic and hydrophilic properties in order to achieve both good lubrication and a short disintegration time.
- a medium polar lubricant is the best compromise such as Fumaric acid.
- Surfactants such as sodium lauryl sulfate and magnesium lauryl sulfate also act as lubricants.
- Extrinsic lubrication is provided via mechanisms that apply a lubricating substance, normally paraffin oil, to the tableting tool surface during processing.
- a lubricating substance normally paraffin oil
- One method makes use of an oiled felt washer attached to the lower punch below the tip. This washer wipes the die cavity with each tablet ejection. To avoid having tablets stick to the punch faces, materials such as polytetrafluorethylene or polyurethane have been applied to the faces.
- Another lubrication method sprays a thin layer of lubricant (either liquid or solid lubricant) onto the tool surfaces after one tablet is ejected and before the granulate of the next tablet enters the die cavity. Products containing acetylsalicylic acid do not usually require additional lubrication.
- Glidants are usually not necessary. Free-flowing granulates, ingredients of appropriate physical form for direct compression, and the large tablet diameters make it possible to exclude the use of glidants.
- Binders are commonly used when making conventional tablets.
- the binders are either added in dry form or dissolved in a suitable solvent and then added in connection with a wet-granulation process.
- Most binders are polymers and increase the plastic deformation of the formulation.
- the use of binders will normally prevent a rapid dissolution of the effervescent tablet.
- Effervescent granules may be formulated with binders since their large surface area, when compared with that of the conventional or the effervescent tablet will result in rapid dissolution.
- citric acid dissolved during the massing function as a binder.
- binders such as polyvinylpyrrolidone (polyvidone) or polyvinylpyrrolidone-poly(vinyl acet-ate)-copolymer, led to a change of color on the part of the ascorbic acid granules.
- Hydrogenated maltodextrins containing high amounts of maltitol were chosen, according to embodiments of the present invention, from a wide range of dextrins and maltodextrins as possible binders.
- Maltitol is a suitable binder for ascorbic acid effervescent tablets. Formation of crystal bridges of maltitol is the assumed binding mechanism, PEG 6000 may function both as a binder and as a lubricant.
- Disintegrants which are used in conventional tablets, are not normally used in effervescent tablets because one of the marketing demands is that a clear solution should be obtained within a few minutes after adding the tablet to a glass of cold water.
- Suitable emulsifier or surfactant may be added for better incorporation of liquid aromatic oils into dry tablet formulation and its better dispersibility on the skin.
- an antifoaming agent such as polydimethyl-siloxane
- antifoaming agents do not normally form constituents of effervescent products.
- Effervescent compositions may be markedly stabilized if the NaHCO 3 is partly converted to the corresponding carbonate. Usually, the desired degree of stability is attained if approximately 2-10% of the weight of the bicarbonate is converted to the carbonate.
- Vitamin C Ascorbic acid—can serve also as acid for effervescent reaction
- group of Vitamins B B1 (thiamin), B2 (riboflavin), B3 (Niacin), B6 (pyridoxine), Pro-vitamin B5 (Panthenol), B9 (Folic Acid), B12 (cobalamin).
- Vitamins can serve as moisturizing, anti-oxidant, wrinkle reduction, skin whitening and anti-acne activity.
- Plant extracts in powder form can be used in both water soluble and water non-soluble forms.
- Water non-soluble powder plant extracts can serve as a natural mechanical peeling and toxins/dirt absorbing agent.
- Plant extracts can serve as moisturizing, anti-oxidant, wrinkle reduction, skin whitening, slimming and anti-acne activity, for example caffeine.
- Plant extracts and oils can serve also as aromatic additives.
- Malic, maleic, lactic, salicylic, fruit acids, glycolic acid, hydroxyoctanoic acid, azelaic acid and mixtures of these as well as their salts may serve as chemical peeling for wrinkle reduction, skin whitening and anti-acne activity.
- Suitable amino acids include, e.g., L-tyrosine, isoleucine, ornithine, glutamine, phenylalanine, leucine, lysine, methionine, threonine, taurine, tryptophan, valine, alanine, glycine, arginine, histidine, cysteine, asparagine, pro line and serine, and mixtures thereof.
- Polysaccharides that may be useful according to embodiments of this invention are dry solid anhydrous substances such as sorbitol, sugars, (such as trehalose) starches, modified starches (e. g. aluminum octenyl succinate) and mixtures thereof.
- These actives are water soluble powders, can serve as moisturizing and film forming/emollients agents during and after application. Their film forming activity has usually a soothing effect.
- Alginic acid, guar gum and algae extracts are typical examples. These materials may also serve as dirt absorbing and water swelling medium during and after application.
- Starches are also suitable emollients. Typical of this class is tapioca and arabinogalactan.
- polyssacharides and their derivates can serve as tablet formulation binders: starches, natural gums, cellulose gums, microcrystalline cellulose, methylcellulose, cellulose ethers, sodium carboxymethylcellulose, ethylcellulose, gelatin, dextrose, lactose, sucrose, sorbitol, mannitol, polyethylene glycol, polyvinylpyrrolidone, pectins, alginates, polyacrylamides, polyvinyloxoazolidone, polyvinylalcohols and mixtures thereof.
- Gliding agent such as PEG-14M (usable in shaving gels)
- PEG-14M usable in shaving gels
- Examples of minerals which may be used as additives to tablets for skin treatment according to embodiments of the present invention include calcium, iron, zinc, selenium, copper, iodine, magnesium, phosphorus, chromium and mixtures thereof.
- the base which is capable of generating carbon dioxide is also considered as mineral.
- suitable carbonate bases include sodium bicarbonate, sodium carbonate, sodium sesquicarbonate, potassium carbonate, potassium bicarbonate, calcium carbonate, magnesium carbonate, magnesium oxide, sodium glycine carbonate, L-lysine carbonate, arginine carbonate, zinc carbonate, zinc oxide and mixtures thereof.
- Some natural minerals such as sodium or magnesium, magnesium silicate and bentonites can serve also as swelling agents.
- Some minerals such as magnesium oxide or zeolites can serve for exothermic effect during water addition.
- Antibacterials and fungicidals may be included as skin benefit agents. Representative of these categories are triclosan, tricloban, hexetidene, chlorhexadene, gluconates, zinc salts (e. g. zinc citrate and zinc phenolsulfonate) and combinations thereof.
- Benzoyl peroxide is known as very effective treatment for acne and may be added to tablet for skin treatment according to embodiments of the present invention.
- Menthol, camphor, methyl salicylate, clove oil, allantoin, benzyl alcohol may be used as pain relief and/or inflammatory agents for use as ingredients of a tablet for skin treatment according to embodiments of the present invention.
- Surfactants such as polysorbate 80 and sodium lauryl sulfate may serve for cleansing of the skin or as surfactant aid during tablet formulation when added to tablets for skin treatment.
- Emollients may be in the form of natural or synthetic esters/waxes, silicone oils/waxes, hydrocarbons, starches, fatty acids and mixtures thereof, including bees wax, silicon waxes, bee pollen, bran, wheat germ, kelp, cod liver oil, ginseng, and fish oils, glucosamine, chondroitin, methylsulfonylmethane, and mixtures thereof.
- a long list of additives may be included in skin treatment tablets for anti-aging activity, according to embodiments of the present invention.
- Additives typical of this category that may be added to skin treatment tablets are niacinamide, kojic acid, arbutin, vanillin, ferulic acid and esters thereof; resorcinol, hydroquinone, placental extract and combinations thereof.
- One effervescent tablet made with weights 1.5 grams (1500 mg), formula for 1 piece of Vitamin C effervescent tablets:
- a preferable binder for use in the preparation of skin treatment tablets according to embodiments of the present invention is PVP because PVP is a water soluble binder and a selected concentration of 3% of PVP for use as a binder may be selected because in pharmaceutical formulations and technology a typical range is 0.5 to 5%.
- sucrose may be used, because filler used in the effervescent tablet is sugar.
- concentrations of the selected filler may be, e.g. 15%.
- the acid that may be used is a combination of citric acid monohydrate and tartaric acid which is adapted to formulate tablets with strong effervescent effect.
- the produced granules When using citric acid monohydrate only, the produced granules may be sticky and soft, so it can not be compressed, whereas when used in single-tartaric acid the produced effervescent tablets may be hard and crack able.
- Sodium bicarbonate may be used as base.
- PEG 8000 may be used as lubricant.
- FIG. 1 is a flow diagram illustrating method of applying cosmetic skin treatment, according to embodiments of the present invention.
- a first active material and a second active material (blocks 12 and 14 ) are provided. These materials may be included in a tablet and may be activated in the presence of a liquid, such as water, gel or other kinds of liquid.
- a liquid such as water, gel or other kinds of liquid.
- gliding liquid such as water or gel and/or additives of various kinds and for various purposes may also be provided (block 15 ), as discussed in details above.
- the first and second active materials are allowed to chemically react and to liberate gas (such as carbon dioxide) through effervescent effect (block 16 ).
- granules of at least the first active material may be lessened due to the chemical reaction.
- the rate of the chemical reaction may be controlled, for example by controlling the rate of supply of the activating liquid, by controlling the temperature of the reaction or its pressure, etc.
- granules of at least the first active material may penetrate into the treated skin deeper than in known cosmetic treatments and therefore may remove undesired skin cells from deeper skin layers.
- the effervescent effect may also assist in providing the additives of the treatment tablet deeper into the skin layers. In case when exothermic additives are used the exothermic effect may amplify the penetration effect of the bubbling gas even more.
- the skin treatment tablet may be applied onto the treated skin using one of the various tablet holders/holding means described in details below by providing buffing movements over the skin on the treated area (block 18 ) resulting removal of undesired layers of skin.
- the rate of the chemical reaction may be controlled to control one or more of the rate of lessening of the size of granules of the first active material and the amount of gas produced during the chemical reaction (block 20 ).
- FIGS. 1A , 1 B, 1 C, and 1 D show apparatuses for holding a shaped tablet according to embodiments of the present invention comprising a tablet 100 ; and structures 102 or 104 .
- Tablet 100 can be shaped into various shapes.
- the shaped tablet can be fitted with various structures and devices.
- solid 100 is shaped into a curved surface and may be fitted within structure 102 , 104 .
- Structures 102 , 104 include handle 106 , 108 respectively. Handle 106 , 108 allow the user to scrub solid 100 against user's body. By wetting the area to be scrubbed and scrubbing the area with tablet 100 , tablet 110 dissolves while cleaning the area. The scrubbing further generates cleaning foam.
- FIGS. 2A and 2B show apparatuses for holding a shaped tablet according to embodiments of the present invention.
- Apparatus 202 may be shaped as a lipstick container, comprising solid 200 shaped as stick; and a brush 206 or scrapper 208 .
- Container 202 can rotate to expose/hide solid 200 , similar to operation of a lipstick container.
- Cap 204 may be used to cover the remaining of the exposed solid 200 .
- Attachments 206 , 208 may be used to scrub the user's skin while generating foam with the remains of the dissolved solid, or to scrub the skin with the foamed solid.
- the attachments may be removed and replaced as needed.
- FIGS. 3A and 3B depict applicators for holding a shaped tablet according to embodiments of the present invention.
- Applicators 304 ; 306 are shaped as a wide and narrow applicators, respectively.
- Applicators 304 , 306 comprise solids/tablets 300 , 302 and scrappers 308 , 310 , respectively.
- FIGS. 4A , 4 B and 4 C and FIGS. 5A and 5B show liquid containers and tablet holders according to embodiments of the present invention.
- Tablet 400 may comprise channel/s 402 allowing liquids to pass through while dissolving the tablet.
- Tablet 400 may further comprise mounting base 408 shaped as a web.
- Mounting base 408 may be meshed within solid 400 , thus allowing affixing a dissolved tablet.
- Mounting base 408 may be mounted within connector 406 .
- Connector 406 may further comprise holes 404 . Holes 404 may allow liquids, for example from container 412 , to pass through while wetting the surface in contact with tablet 400 .
- Sealer 410 may fit connector 406 over the opening of squeezable container 412 .
- Squeezing squeezable container 412 may extract contained liquids throughout holes 404 and/or channels 402 while dissolving tablet 400 .
- the inner surface of tablet 400 which faces the inner part of the squeezable container opening, may dissolve and foam while creating pressure within container 412 .
- the inner foam is also pressurized extract with the squeezed liquids.
- FIGS. 6A , 6 B, 6 C and 6 D show various shapes of capsule tablets according to embodiments of the present invention.
- Tablet 600 may comprise projections 602 ;
- Tablet 604 may comprise stripes 606 and tablet 608 may comprise holes 610 .
- Tablet 612 may comprise meshed snap-on locator 614 .
- FIGS. 7A and 78 show various forms of squirter 701 comprising capsule shaped tablet according to embodiments of the present invention.
- Solid 700 , 704 may comprise adjustment ring 702 , 706 respectively. Adjustment ring 702 , 706 may fit within niche 708 .
- Pressing button 712 may squirt contained liquids through nozzle 710 . Squirting contained liquids from within container 716 , while rubbing affixed tablet 700 , 704 may scrub the skin while dissolving the solid over the rubbed skin.
- Cap 714 can be removed in order to fill, refill or empty container 716 .
- FIGS. 8A and 8B show squirter 801 similar to squirter 701 of FIGS. 7A and 7B featuring a rotation and vibration movements applicable to the solid/tablet of the present invention.
- a preferred embodiment of Squirter 801 may further comprise batteries cap 804 , rotation and/or vibration activation button 806 and rotation and/or vibration movement source 808 fitted with the solid. Activating the rotation and/or vibration source during treatment may further scrub the solid against the skin. The activation button further controls the squirting through the nozzle.
- Cap 802 can be removed in order to fill or empty container 800 .
- FIGS. 9A and 9B show mouth hygiene apparatuses 901 , 911 comprising a solid/tablet according to embodiments of the present invention.
- Apparatus 901 comprising handle 902 adapted to hold solid 900 at its end, wherein solid 900 may be shaped to enable scrubbing inside the mouth cavity.
- Solid 900 may fit the size of tooth, between tooth, and tongue.
- Apparatus 911 may comprise handle 912 comprising bristles 906 fitted over flexible arm 910 .
- Flexible arm 910 allows bristles 906 to withdraw during brushing thus keeping the remains of the dissolved solid 904 in contact with the brushed surface.
- FIGS. 10A , 10 B and 10 C show handheld evaporative humidifier apparatuses 1004 , 1011 and 1004 , respectively, comprising a solid/tablet according to embodiments of the present invention.
- Handheld evaporative humidifier 1004 may generate fogged liquids. The fogged liquids may wet the area in front of nozzle 1002 thus foaming scrubbed solid 1000 .
- Controller 1014 may control the evaporator, for example by inducing an electrical field with changing filed strength.
- Handheld evaporative humidifier 1004 may comprise lid 1006 for filling/refilling contained liquids, and power source chamber 1012 for placing/replacing power source unit, such as batteries/chargeable batteries.
- Solid 1000 may comprise snap on cap 1010 which may be adapted to fit onto connector 1008 .
- FIGS. 11A , 11 B and 11 C depict skin treatment tool 1100 adapted to operate with skin treatment tablet 1106 , according to embodiments of the present invention, in side view, bottom view and blown view, respectively.
- Apparatus 1100 may comprise gel container 1102 which is formed to contain gel and to be used also as a handle.
- Gel container 1102 may be connected to mediator element 1104 at a first end of it.
- Mediator 1104 may comprise a gel passage allowing gel to flow from gel container 1102 towards tablet 1106 connectable to the other end mediator 1104 .
- Tablet 1106 may be formed to fit onto the other end of mediator element 1104 and may be connected to it by one of various possible means, such as snap-to, adhesive, and others.
- Tablet 1108 may be formed with hole 1108 in it. Hole 1108 may fit the gel passage (not shown) leading gel from gel container 1102 so as to allow gel to flow through it and wet the outer surface of tablet 1106 .
- the outer circumference 1105 of mediator 1104 may be formed with rounded and soft edge on the side facing the treated skin to provide soft and smooth touch with the skin when approaching the end of the tablet during treatment. Outer circumference 1105 may be formed to protrude outwardly from the diameter of gel container 1102 , to prevent undesired touch of long nails with the treated skin.
- FIGS. 12 , 12 A and 12 B are a blow-up view of skin treatment tool 1200 , a partial sectional view of treatment tool 1202 and a top view of mediator 1206 , respectively, according to embodiments of the present invention.
- Skin treatment tool 1200 may comprise gel container 1202 comprising gel passage 1222 at one end.
- Tool 1200 may further comprise gel cap/adaptor 1204 adapted to receive gel container or compartment 1202 , for example by snap-on or thread connecting means.
- Gel cap 1204 comprises also gel passage 1223 adapted to receive flow of gel from gel container 1202 through input passage 1224 and is made so that its output passage 1226 is located off-center of cap 1204 , so that when mediator 1206 is rotated with respect to cap 1204 one of several holes 1230 made in mid-partition 1206 A, each having different diameter, may be placed, one at a time, against output end passage 1226 of gel, thus providing control means of the rate of flow of gel towards mediator 1206 .
- Mediator 1206 may further comprise tablet compartment 1207 formed to comprise treatment tablets according to embodiments of the present invention. Tablet compartment 1207 may be capped by tablet cap 1208 adapted to connect onto mediator 1206 so as to close tablet compartment 1207 and contain a tablet in there.
- Tablet cap 1208 may comprise gel outlet hole 1208 A, made to allow flow of gel out side of tool 1200 .
- mediator 1206 may have made in its mid-partition 1206 A several holes (or gel passages) 1230 A, 1230 B, etc., each having different diameter to provide different gel flow capacity.
- Mid-partition 1206 A may also comprise blocked passage location 1230 C to allow inactive mode of tool 1200 . It would be apparent to one skilled in the art that mid-partition 1206 A may comprise more than two holes with different diameters. It would also be apparent to a person skilled in the art that other means of controlling the rate of flow of gel may be employed without departing from the scope of embodiments of the present invention.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Cosmetics (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicinal Preparation (AREA)
Abstract
An apparatus and method for providing cosmetic treatment to skin comprise one material chemically active in a solid form preferably in a tablet form and a second material which is chemically reactive with the first material so that effervescence is produced during the reaction. The chemically active materials may be activated by a user for providing cosmetic treatment to skin. The activation releases effervescence which urges granules of the reacting materials onto the skin. The size of the granules lowers during the reaction thus providing continuously refining peeling to the skin.
Description
- This application claims the benefit of U.S. Ser. No. 61/482,302, filed on May 4, 2011 (and entitled SYSTEM AND METHOD FOR USING BUBBLING TABLETS FOR COSMETIC CARE), which is incorporated in its entirety herein by reference.
- The present invention relates to method and apparatus for applying cosmetic treatment to skin and more particular, method for applying cosmetic treatment to skin using effervescent chemical composition and to apparatus for applying such treatment.
- Facial skin cleaning, brightening or rejuvenating by chemical treatment, laser treatment or by exfoliation using machine driven means are known in the art. Such methods typically require medical supervision and involve some risk of damaging side effects, pain and discomfort during treatment. These methods typically require long recovery time between treatments. Also known in the art are methods for using creams comprising granules (or microcrystals), such as of alumina, which are applied to the outer layers of the skin using mechanical means such as a vibrator. These methods achieve limited level of penetration of the resurfacing microcrystals into the treated skin and suffer of a fix level of skin cells removal as dictated by the size of the microcrystals throughout the treatment.
- Method and means for skin treatment that provide high level of penetration of the treating material into the skin, that gradually lowers the level of skin cell removal throughout the treatment to provide improved final level of skin smoothness and that may be safely applied, preferably by the person himself, with no pains or recovery time, are desired. The desired method and means should be inexpensive and easily achievable, virtually anywhere.
- The present invention will be understood and appreciated more fully from the following detailed description taken in conjunction with the appended drawings in which:
-
FIG. 1 is a flow diagram illustrating method of applying cosmetic skin treatment, according to embodiments of the present invention; -
FIGS. 1A , 1B, 1C, and 1D show apparatuses for holding a shaped tablet according to embodiments of the present invention; -
FIGS. 2A and 2B show apparatuses for holding a shaped tablet according to embodiments of the present invention; -
FIGS. 3A and 3B depict applicators for holding a shaped tablet according to embodiments of the present invention; -
FIGS. 4A , 4B and 4C andFIGS. 5A and 5B show liquid containers and tablet holders according to embodiments of the present invention; -
FIGS. 6A , 6B, 6C and 6D show various shapes of capsule tablets according to embodiments of the present invention; -
FIGS. 7A and 7B show various forms of a squirter apparatus comprising capsule shaped tablet according to embodiments of the present invention; -
FIGS. 8A and 8B show a squirter similar to the squirter ofFIGS. 7A and 7B featuring a rotation and vibration movements applicable to a tablet of the present invention; -
FIGS. 9A and 9B show mouth hygiene apparatuses comprising a tablet according to embodiments of the present invention; -
FIGS. 10A , 10B and 10C show handheld evaporative humidifier apparatuses comprising each a tablet according to embodiments of the present invention; -
FIGS. 11A , 11B and 11C depict skin treatment tool adapted to operate with skin treatment tablet according to embodiments of the present invention, in side view, bottom view and blown view, respectively; and -
FIGS. 12 , 12A and 12B depict a blow-up view ofskin treatment tool 1200, a partial sectional view oftreatment tool 1202 and a top view ofmediator 1206, respectively, according to embodiments of the present invention. - The following detailed description of the invention refers to the accompanying drawings referred to above. Dimensions of components and features shown in the figures are chosen for convenience or clarity of presentation and are not necessarily shown to scale. Wherever possible, the same reference numbers will be used throughout the drawings and the following description to refer to the same and like parts.
- Skin treatment in general and cosmetic skin treatment more particularly employ a variety of means and materials aimed to serve a variety of targets, such as removal of the epidermal layer (upper/outer layer) of the skin, lightening the skin color, applying of aromatic or moisturizing materials, applying medical compositions, vitamins or disinfectants, etc. Such treatment means and materials as known in the art are typically expensive and have limited effect due to their limited ability to penetrate into, or through the upper-most outer layer of the epidermal skin layer.
- According to embodiments of the present invention the well known phenomena of the effervescence effect of the chemical reaction of certain first and second materials, such as baking soda (sodium bicarbonate) with certain other materials, such as citric acid (C6H8O7(aq) may be utilized in cosmetic skin treatment to achieve improved treatment results with respect to the depth of removed epidermis layer, the level of penetration of treating materials into the skin and the final smoothness of the treated skin at the end of the treatment. The first material may be a base with low value of pH, for example lower than 7 and the second material may be acidic with high value of pH, for example higher than 7. As is well known the chemical reaction of baking soda with citric acid is defined by:
- Similarly, the chemical reaction of tartaric acid with sodium bicarbonate is defined by:
- This phenomenon may be utilized, according to embodiments of the present invention, by using the gas that is released during the reaction (e.g. CO2) to push and force the treating material granules into the treated skin, deeper than is possible without the assistance of the released gas. The treating material may be, according to embodiments of the present invention, merely the granules of the first active material, e.g. baking soda or sodium bicarbonate. In some embodiments the treating material may also contain granules of one or more of materials produced during the chemical reaction. These granules may act on the skin like an emery paper when buffed into the treated skin. The treating reacting material or materials may be buffed into the skin using one or more of the various means presented and described in details below. The phenomenon described above may also be used for skin cosmetic treatment using means other than those described in this application, as long as the reacting at least two materials are applied into the treated skin in a buffing manner. It will be appreciated by a person skilled in the art that other solutions may be used, which, when reacting, create effervescence effect. It will also be apparent to a person skilled in the art that the first and/or second materials may be provided in any adequate phase, e.g. solid, powder, liquid, gel or gas—as long as their chemical reaction will provide granules and gas. In some embodiments at least one of the first and second active materials may be provided in liquid form (e.g. dissolved in water or the like) or dissolved in gel. The liquid or gel in which one of the active materials is dissolved may be used, according to embodiments of the present invention as a wetting, gliding or oiling material to provide smoother gliding of an apparatus of the present invention with treated skin. According to additional embodiment the carrying liquid and/or gel may be used to provide treating materials to the treated skin. The chemical features of such carrying liquid or gel may be selected as may be desired, e.g. to have no effect on the chemical reaction, to release one or more product materials that has positive effect on the treated skin, as may be required, etc.
- According to yet further embodiments of the present invention the continuing decrease in the size of the granules of the reacting first material, e.g. baking soda, due to the chemical reaction, may be utilized for continuous refining of the level of epidermis removal, resulting in refined smoothness of the skin at the end of the treatment. This may last as long as the emery paper effect of the particles is effective for removal and/or smoothing the treated skin. According to embodiments of the present invention the initial size of the granules of the first material may be selected for treatment with a defined level of initial skin removal capacity and the rate of granules size reduction may be controlled to fit the specific treatment needs. It will be appreciated by a person skilled in the art that other solutions may also be used according to embodiments of the present invention which, when reacting, act on the granules of at least one active material to reduce their size during the reaction.
- According to embodiments of the present invention the treating materials may be provided in the form of a tablet that may have defined from, that may contain the required materials for achieving the required treatment goals and that may be applied to the treated skin during the treatment using specially designed apparatuses, as is described in details herein below. The term ‘tablet’, as used throughout this specification, relates to material or materials that are adapted to participate in a chemical reaction and that are provided in a solid form, having a defined shape, where not all of the materials contained in the tablet necessarily adapted to participate in that chemical reaction. Additionally to treatment effects according to the present invention that were mentioned above, tablets made according to embodiments of the invention may comprise, additionally to the first and second active materials, materials for treating the skin, for lightening its color, for providing odors, for providing vitamins, for casing exothermic effect, etc. The amount of each of the ingredients in a tablet, as well as their order of release, their level of solubility and other respective features may be set so as to fulfill the treatment goals it is designed for, as is explained in details below. US application Publication No. 2008/0146487 (O'Connor et al.), to which reference is made now, describes certain possible uses of tablets with numerous ingredients for providing different phases of user experience when bathing. The described tablets are made for dissolving in the bath water and are made of several layers of the desired materials so that the release of each layer, in its turn, into the bath water, provides different user experience. However, US 2008/0146487 does not disclose or suggest direct application of the tablets on a human's skin for achieving cosmetic treatment effects, nor does it disclose use of the effervescence effect for enhancing the cosmetic treatment effect or reliance on the lessening size of granules of material in the tablet for controlling the cosmetic treatment effect so as to refine the final smoothness of the skin. Moreover, effects of materials included in the tablets described in US 2008/0146487 on the user's skin are limited to the exposure of the skin to their presence next to the user's body, after the tablet is dissolved in the amount of bath water, typically tens of liters or more. For example, use of exothermic ingredients in the tablets disclosed in US 2008/0146487 is expected to have very limited experience effect for a bathing user when this ingredient is dissolved in tens of mild temperature liters of water.
- The choice of ingredients for effervescent granules may be deducted both by the requirement of the manufacturing process and the necessity of making a preparation which dissolves in water. The required ingredients are at least one acid and at least one base. The base should release, according to embodiments of the present invention, carbon dioxide upon reaction with the acid. Examples of such acids may include tartaric acid and citric acid. Examples of bases include sodium carbonate, potassium bicarbonate, sodium bicarbonate. Effervescent granules may usually be prepared from a combination of citric and tartaric acid rather than from a single acid because the use of either acid alone may cause difficulties. When tartaric acid is the sole acid, the resulting granules readily crumble and lack mechanical strength. Citric acid alone may result in a sticky mixture which is difficult to granulate during the manufacturing process. Effervescent salts may include the following ingredients, which may actually produce the effervescence: sodium bicarbonate, citric acid and tartaric acid. When added to water the acids and base may react to liberate carbon dioxide, resulting in effervescence. It should be noted that any acid-base combination which results in the liberation of carbon dioxide could be used in place of this combination as long as the ingredients are suitable for pharmaceutical use.
- The reaction between citric acid and sodium bicarbonate and tartaric acid and sodium bicarbonate, which results in liberation of carbon dioxide, has been shown above in formulas (1) and (2). It should be noted that it requires 3 molecules of sodium bicarbonate to neutralize 1 molecule of citric acid and 2 molecule of sodium bicarbonate to neutralize 1 molecule of tartaric acid. The proportion of acids may be varied, as long as the total acidity is maintained and the bicarbonate completely neutralized. Usually it is desired that ratio of citric acid to tartaric acid equals 1:2 so that the desired ratio of the ingredients can be calculated as follows:
-
Citric acid:Tartaric acid:Sodium bicarbonate=1:2:3.44 (by weight) (3) - The United States Pharmacopeia (USP) 24 includes the following seven monographs, that may be used for tablets according to embodiments of the present invention:
- 1. Acetaminophen for Effervescent Oral Solution;
- 2. Aspirin Effervescent Tablets for Oral Solution;
- 3. Potassium Bicarbonate Effer-vescent Tablets for Oral Solution;
- 4. Potassium Bicarbonate and Potassium Chloride for Effervescent Oral Solution;
- 5. Potassium Bicarbonate and Potassium Chloride Efferves-cent Tablets for Oral Solution;
- 6. Potassium and Sodium Bicarbonates and Citric Acid for Oral Solution; and
- 7. Potassium Chloride, Potassium Bicarbonate, and Potassium.
- A perfect lubricant for effervescent products must be nontoxic and water-soluble. Very few traditional lubricants fulfill these requirements. Intrinsic lubricants are added to the powder mixture and consequently included in the formulation. When added in solid form, the lubricant will have to be finely divided. Metal stearates, such as magnesium or calcium stearate that serve as lubricants in conventional tablets, are seldom used as intrinsic lubricants in connection with effervescent tablets due to their insolubility in water. Use of stearates results in an undissolved, foamy, soapy-tasting layer on the surface of the cloudy solution. In addition, normal lubricant concentrations of metal stearates make the tablets hydrophobic, which entails a slow dissolution of the effervescent tablet in the water.
- However, very low concentrations of metal stearates can be used to improve the rate of solution of effervescent tablets as the tablet will remain immersed in the water during dissolution and not float to the surface the way a tablet without metal stearate would. A floating tablet presents a smaller surface area to the water than a tablet immersed in the liquid. Sodium stearate and sodium oleate are water-soluble in low concentrations. They have the characteristic soapy taste, which virtually precludes their use in oral effervescent products but can be used for topical applications. A combination of 4% polyethylene glycol (PEG) 6000 and 0.1% sodium stearyl fumarate proved to be a good lubricant for ascorbic acid tablets made by direct compression on a small scale. Sodium chloride, sodium acetate, and D,L-leucine (water-soluble lubricants) also have been suggested for effervescent tablets. The lubricant used in effervescent formulations should combine hydrophobic and hydrophilic properties in order to achieve both good lubrication and a short disintegration time. A medium polar lubricant is the best compromise such as Fumaric acid. Surfactants such as sodium lauryl sulfate and magnesium lauryl sulfate also act as lubricants.
- Extrinsic lubrication is provided via mechanisms that apply a lubricating substance, normally paraffin oil, to the tableting tool surface during processing. One method makes use of an oiled felt washer attached to the lower punch below the tip. This washer wipes the die cavity with each tablet ejection. To avoid having tablets stick to the punch faces, materials such as polytetrafluorethylene or polyurethane have been applied to the faces. Another lubrication method sprays a thin layer of lubricant (either liquid or solid lubricant) onto the tool surfaces after one tablet is ejected and before the granulate of the next tablet enters the die cavity. Products containing acetylsalicylic acid do not usually require additional lubrication.
- Glidants are usually not necessary. Free-flowing granulates, ingredients of appropriate physical form for direct compression, and the large tablet diameters make it possible to exclude the use of glidants.
- The adherence of the granulate or powder mixture to the surfaces of the apparatus used to apply a tablet according to embodiments of the present invention, so-called picking, can be eliminated by using discs, such as those made of polytetrafluorethylene or poly-urethane, cemented to the punch surfaces of the apparatus.
- Binders are commonly used when making conventional tablets. The binders are either added in dry form or dissolved in a suitable solvent and then added in connection with a wet-granulation process. Most binders are polymers and increase the plastic deformation of the formulation. The use of binders will normally prevent a rapid dissolution of the effervescent tablet. Effervescent granules may be formulated with binders since their large surface area, when compared with that of the conventional or the effervescent tablet will result in rapid dissolution. At effervescent granulation composed of anhydrous citric acid and NaHCO3 made with dehydrated alcohol as the granulating liquid, citric acid dissolved during the massing function as a binder.
- In order to compress ascorbic acid from a combination with NaHCO3, granulation is required. Common water-soluble binders, such as polyvinylpyrrolidone (polyvidone) or polyvinylpyrrolidone-poly(vinyl acet-ate)-copolymer, led to a change of color on the part of the ascorbic acid granules. Hydrogenated maltodextrins containing high amounts of maltitol were chosen, according to embodiments of the present invention, from a wide range of dextrins and maltodextrins as possible binders. Maltitol is a suitable binder for ascorbic acid effervescent tablets. Formation of crystal bridges of maltitol is the assumed binding mechanism, PEG 6000 may function both as a binder and as a lubricant.
- Disintegrants, which are used in conventional tablets, are not normally used in effervescent tablets because one of the marketing demands is that a clear solution should be obtained within a few minutes after adding the tablet to a glass of cold water.
- Various dry flavors are available. The flavors used must be water-soluble or water-dispersible. Suitable emulsifier or surfactant may be added for better incorporation of liquid aromatic oils into dry tablet formulation and its better dispersibility on the skin.
- This type of excipient is sometimes used to increase the wetting and dissolution rate of drugs and actives. Attention must be paid to the formation of foam.
- To reduce the formation of foam, and consequently the tendency of additives to the tablet to stick surfaces nest to the water border line, an antifoaming agent, such as polydimethyl-siloxane, can be used. However, antifoaming agents do not normally form constituents of effervescent products.
- The greatest problem with effervescent products is the loss of reactivity with time if exposed prematurely to moisture (i.e., the stability of the effervescent system). In addition, the stability of tablet additives and some excipients, such as flavors, also must be considered. Effervescent compositions may be markedly stabilized if the NaHCO3 is partly converted to the corresponding carbonate. Usually, the desired degree of stability is attained if approximately 2-10% of the weight of the bicarbonate is converted to the carbonate.
- Water soluble vitamins which can be incorporated in a powder form are preferred: Vitamin C (Ascorbic acid—can serve also as acid for effervescent reaction), group of Vitamins B (B1 (thiamin), B2 (riboflavin), B3 (Niacin), B6 (pyridoxine), Pro-vitamin B5 (Panthenol), B9 (Folic Acid), B12 (cobalamin). But to some extent, fat soluble vitamins such as A, E, D, F, K and their derivates and co-enzymes can be added for a spread on and rubbing/massage stage of topical application. Vitamins can serve as moisturizing, anti-oxidant, wrinkle reduction, skin whitening and anti-acne activity.
- Plant extracts in powder form can be used in both water soluble and water non-soluble forms. Water non-soluble powder plant extracts can serve as a natural mechanical peeling and toxins/dirt absorbing agent. Plant extracts can serve as moisturizing, anti-oxidant, wrinkle reduction, skin whitening, slimming and anti-acne activity, for example caffeine. Plant extracts and oils can serve also as aromatic additives.
- Malic, maleic, lactic, salicylic, fruit acids, glycolic acid, hydroxyoctanoic acid, azelaic acid and mixtures of these as well as their salts may serve as chemical peeling for wrinkle reduction, skin whitening and anti-acne activity.
- These actives are mostly water soluble powders, and may serve as moisturizing and film forming/emollients agents during and after application of the cosmetic skin treatment according to embodiments of the present invention. Suitable amino acids include, e.g., L-tyrosine, isoleucine, ornithine, glutamine, phenylalanine, leucine, lysine, methionine, threonine, taurine, tryptophan, valine, alanine, glycine, arginine, histidine, cysteine, asparagine, pro line and serine, and mixtures thereof.
- Polysaccharides that may be useful according to embodiments of this invention are dry solid anhydrous substances such as sorbitol, sugars, (such as trehalose) starches, modified starches (e. g. aluminum octenyl succinate) and mixtures thereof. These actives are water soluble powders, can serve as moisturizing and film forming/emollients agents during and after application. Their film forming activity has usually a soothing effect. Alginic acid, guar gum and algae extracts are typical examples. These materials may also serve as dirt absorbing and water swelling medium during and after application. Starches are also suitable emollients. Typical of this class is tapioca and arabinogalactan. Furthermore, polyssacharides and their derivates can serve as tablet formulation binders: starches, natural gums, cellulose gums, microcrystalline cellulose, methylcellulose, cellulose ethers, sodium carboxymethylcellulose, ethylcellulose, gelatin, dextrose, lactose, sucrose, sorbitol, mannitol, polyethylene glycol, polyvinylpyrrolidone, pectins, alginates, polyacrylamides, polyvinyloxoazolidone, polyvinylalcohols and mixtures thereof.
- Gliding agent, such as PEG-14M (usable in shaving gels), can ease the gliding of tablet on the skin during the application. It also can serve as binder during tablet production.
- Examples of minerals which may be used as additives to tablets for skin treatment according to embodiments of the present invention include calcium, iron, zinc, selenium, copper, iodine, magnesium, phosphorus, chromium and mixtures thereof. The base which is capable of generating carbon dioxide is also considered as mineral. Examples of suitable carbonate bases include sodium bicarbonate, sodium carbonate, sodium sesquicarbonate, potassium carbonate, potassium bicarbonate, calcium carbonate, magnesium carbonate, magnesium oxide, sodium glycine carbonate, L-lysine carbonate, arginine carbonate, zinc carbonate, zinc oxide and mixtures thereof. Some natural minerals such as sodium or magnesium, magnesium silicate and bentonites can serve also as swelling agents. Some minerals such as magnesium oxide or zeolites can serve for exothermic effect during water addition.
- Antibacterials and fungicidals may be included as skin benefit agents. Representative of these categories are triclosan, tricloban, hexetidene, chlorhexadene, gluconates, zinc salts (e. g. zinc citrate and zinc phenolsulfonate) and combinations thereof. Benzoyl peroxide is known as very effective treatment for acne and may be added to tablet for skin treatment according to embodiments of the present invention.
- Menthol, camphor, methyl salicylate, clove oil, allantoin, benzyl alcohol may be used as pain relief and/or inflammatory agents for use as ingredients of a tablet for skin treatment according to embodiments of the present invention.
- Surfactants such as polysorbate 80 and sodium lauryl sulfate may serve for cleansing of the skin or as surfactant aid during tablet formulation when added to tablets for skin treatment.
- Emollients may be in the form of natural or synthetic esters/waxes, silicone oils/waxes, hydrocarbons, starches, fatty acids and mixtures thereof, including bees wax, silicon waxes, bee pollen, bran, wheat germ, kelp, cod liver oil, ginseng, and fish oils, glucosamine, chondroitin, methylsulfonylmethane, and mixtures thereof.
- A long list of additives may be included in skin treatment tablets for anti-aging activity, according to embodiments of the present invention.
- Additives typical of this category that may be added to skin treatment tablets are niacinamide, kojic acid, arbutin, vanillin, ferulic acid and esters thereof; resorcinol, hydroquinone, placental extract and combinations thereof.
- One effervescent tablet made with weights 1.5 grams (1500 mg), formula for 1 piece of Vitamin C effervescent tablets:
- Vitamin C 500 mg
- Pyridoxine 20 mg
- PVP 3% 45 mg
-
Sucrose 15% 225 mg -
Citric Acid Monohydrate 208 mg - Tartaric Acid 222.9 mg
- PEG 8000 30 mg
- Exemplary calculations for 1500 mg tablet for cosmetic skin treatment according to embodiments of the present invention:
-
Weight of effervescent tablet=1500 mg -
Inner Phase weight (consist of active ingredient, acid, base, binder and filler) (98%)=98/100×1500 mg=1470 mg -
Outer Phase (consists of glidant) (2%)=2/100×1500 mg=30 mg -
Acid and Base weight=Inner phase−(active ingredient+binder+filler)=1470 mg−(520+45+225)mg=680 mg - Citric Acid Monohydrate:
-
Molecular weight=210.13 -
Equivalent number=3 -
Equivalent weight=210.13/3=70.04 - Tartaric Acid:
-
Molecular weight=150.09 -
Equivalent number=2 -
Equivalent weight=150.09/2=75.05 - Sodium Bicarbonate:
-
Molecular weight=84.01 -
Equivalent number=I -
Equivalent weight=84.01/1=84.01 -
70.04 mol Equivalent+75.05 mol Equivalent+84.01 mol Equivalent=680 mg -
229.1 mol Equivalent=680 mg -
mol Equivalent=2.97 -
Citric acid monohydrate=70.04×2.97=208 mg -
Tartaric Acid=75.05×2.97=222.9 mg -
Sodium Bicarbonate=84.01×2.97=249.5 mg - A preferable binder for use in the preparation of skin treatment tablets according to embodiments of the present invention is PVP because PVP is a water soluble binder and a selected concentration of 3% of PVP for use as a binder may be selected because in pharmaceutical formulations and technology a typical range is 0.5 to 5%. As filler sucrose may be used, because filler used in the effervescent tablet is sugar. The concentrations of the selected filler may be, e.g. 15%. The acid that may be used is a combination of citric acid monohydrate and tartaric acid which is adapted to formulate tablets with strong effervescent effect. When using citric acid monohydrate only, the produced granules may be sticky and soft, so it can not be compressed, whereas when used in single-tartaric acid the produced effervescent tablets may be hard and crack able. Sodium bicarbonate may be used as base. PEG 8000 may be used as lubricant.
- Reference is made now to
FIG. 1 , which is a flow diagram illustrating method of applying cosmetic skin treatment, according to embodiments of the present invention. A first active material and a second active material (blocks 12 and 14) are provided. These materials may be included in a tablet and may be activated in the presence of a liquid, such as water, gel or other kinds of liquid. Optionally gliding liquid, such as water or gel and/or additives of various kinds and for various purposes may also be provided (block 15), as discussed in details above. The first and second active materials are allowed to chemically react and to liberate gas (such as carbon dioxide) through effervescent effect (block 16). Additionally, during the chemical reaction size of granules of at least the first active material may be lessened due to the chemical reaction. The rate of the chemical reaction may be controlled, for example by controlling the rate of supply of the activating liquid, by controlling the temperature of the reaction or its pressure, etc. As a result of the effervescent effect granules of at least the first active material may penetrate into the treated skin deeper than in known cosmetic treatments and therefore may remove undesired skin cells from deeper skin layers. The effervescent effect may also assist in providing the additives of the treatment tablet deeper into the skin layers. In case when exothermic additives are used the exothermic effect may amplify the penetration effect of the bubbling gas even more. - The skin treatment tablet may be applied onto the treated skin using one of the various tablet holders/holding means described in details below by providing buffing movements over the skin on the treated area (block 18) resulting removal of undesired layers of skin.
- The rate of the chemical reaction may be controlled to control one or more of the rate of lessening of the size of granules of the first active material and the amount of gas produced during the chemical reaction (block 20).
- Illustrative embodiments of means for applying cosmetic treatment tablets according to embodiment of the present invention are described below. In the interest of clarity, not all features/components of an actual implementation are necessarily described.
-
FIGS. 1A , 1B, 1C, and 1D show apparatuses for holding a shaped tablet according to embodiments of the present invention comprising atablet 100; and 102 or 104.structures Tablet 100 can be shaped into various shapes. The shaped tablet can be fitted with various structures and devices. In this preferred embodiment, solid 100 is shaped into a curved surface and may be fitted within 102, 104.structure 102, 104 includeStructures 106, 108 respectively. Handle 106, 108 allow the user to scrub solid 100 against user's body. By wetting the area to be scrubbed and scrubbing the area withhandle tablet 100,tablet 110 dissolves while cleaning the area. The scrubbing further generates cleaning foam. -
FIGS. 2A and 2B show apparatuses for holding a shaped tablet according to embodiments of the present invention.Apparatus 202 may be shaped as a lipstick container, comprising solid 200 shaped as stick; and abrush 206 orscrapper 208.Container 202 can rotate to expose/hide solid 200, similar to operation of a lipstick container.Cap 204 may be used to cover the remaining of the exposed solid 200. -
206, 208 may be used to scrub the user's skin while generating foam with the remains of the dissolved solid, or to scrub the skin with the foamed solid. The attachments may be removed and replaced as needed.Attachments -
FIGS. 3A and 3B depict applicators for holding a shaped tablet according to embodiments of the present invention.Applicators 304; 306 are shaped as a wide and narrow applicators, respectively. 304, 306 comprise solids/Applicators 300, 302 andtablets 308, 310, respectively.scrappers -
FIGS. 4A , 4B and 4C andFIGS. 5A and 5B show liquid containers and tablet holders according to embodiments of the present invention.Tablet 400 may comprise channel/s 402 allowing liquids to pass through while dissolving the tablet.Tablet 400 may further comprise mountingbase 408 shaped as a web. Mountingbase 408 may be meshed within solid 400, thus allowing affixing a dissolved tablet. Mountingbase 408 may be mounted withinconnector 406.Connector 406 may further compriseholes 404.Holes 404 may allow liquids, for example fromcontainer 412, to pass through while wetting the surface in contact withtablet 400.Sealer 410 may fitconnector 406 over the opening ofsqueezable container 412. Squeezingsqueezable container 412 may extract contained liquids throughoutholes 404 and/orchannels 402 while dissolvingtablet 400. The inner surface oftablet 400 which faces the inner part of the squeezable container opening, may dissolve and foam while creating pressure withincontainer 412. The inner foam is also pressurized extract with the squeezed liquids. -
FIGS. 6A , 6B, 6C and 6D show various shapes of capsule tablets according to embodiments of the present invention.Tablet 600 may compriseprojections 602;Tablet 604 may comprisestripes 606 andtablet 608 may compriseholes 610.Tablet 612 may comprise meshed snap-onlocator 614. -
FIGS. 7A and 78 show various forms ofsquirter 701 comprising capsule shaped tablet according to embodiments of the present invention. Solid 700, 704 may comprise 702, 706 respectively.adjustment ring 702, 706 may fit withinAdjustment ring niche 708.Pressing button 712 may squirt contained liquids throughnozzle 710. Squirting contained liquids from withincontainer 716, while rubbing affixed 700, 704 may scrub the skin while dissolving the solid over the rubbed skin.tablet Cap 714 can be removed in order to fill, refill orempty container 716. -
FIGS. 8A and 8B show squirter 801 similar tosquirter 701 ofFIGS. 7A and 7B featuring a rotation and vibration movements applicable to the solid/tablet of the present invention. A preferred embodiment ofSquirter 801, as based onsquirter 701, may further comprisebatteries cap 804, rotation and/orvibration activation button 806 and rotation and/orvibration movement source 808 fitted with the solid. Activating the rotation and/or vibration source during treatment may further scrub the solid against the skin. The activation button further controls the squirting through the nozzle.Cap 802 can be removed in order to fill orempty container 800. -
FIGS. 9A and 9B show 901, 911 comprising a solid/tablet according to embodiments of the present invention.mouth hygiene apparatuses Apparatus 901 comprisinghandle 902 adapted to hold solid 900 at its end, wherein solid 900 may be shaped to enable scrubbing inside the mouth cavity. Solid 900 may fit the size of tooth, between tooth, and tongue.Apparatus 911 may comprise handle 912 comprisingbristles 906 fitted overflexible arm 910.Flexible arm 910 allowsbristles 906 to withdraw during brushing thus keeping the remains of the dissolved solid 904 in contact with the brushed surface. -
FIGS. 10A , 10B and 10C show handheld 1004, 1011 and 1004, respectively, comprising a solid/tablet according to embodiments of the present invention. Handheldevaporative humidifier apparatuses evaporative humidifier 1004 may generate fogged liquids. The fogged liquids may wet the area in front ofnozzle 1002 thus foaming scrubbed solid 1000.Controller 1014 may control the evaporator, for example by inducing an electrical field with changing filed strength. Handheldevaporative humidifier 1004 may compriselid 1006 for filling/refilling contained liquids, andpower source chamber 1012 for placing/replacing power source unit, such as batteries/chargeable batteries. Solid 1000 may comprise snap oncap 1010 which may be adapted to fit ontoconnector 1008. - Reference is made to
FIGS. 11A , 11B and 11C, which depictskin treatment tool 1100 adapted to operate withskin treatment tablet 1106, according to embodiments of the present invention, in side view, bottom view and blown view, respectively.Apparatus 1100 may comprise gel container 1102 which is formed to contain gel and to be used also as a handle. Gel container 1102 may be connected tomediator element 1104 at a first end of it.Mediator 1104 may comprise a gel passage allowing gel to flow from gel container 1102 towardstablet 1106 connectable to theother end mediator 1104.Tablet 1106 may be formed to fit onto the other end ofmediator element 1104 and may be connected to it by one of various possible means, such as snap-to, adhesive, and others.Tablet 1108 may be formed withhole 1108 in it.Hole 1108 may fit the gel passage (not shown) leading gel from gel container 1102 so as to allow gel to flow through it and wet the outer surface oftablet 1106. Theouter circumference 1105 ofmediator 1104 may be formed with rounded and soft edge on the side facing the treated skin to provide soft and smooth touch with the skin when approaching the end of the tablet during treatment.Outer circumference 1105 may be formed to protrude outwardly from the diameter of gel container 1102, to prevent undesired touch of long nails with the treated skin. - Reference is made now to
FIGS. 12 , 12A and 12B which are a blow-up view ofskin treatment tool 1200, a partial sectional view oftreatment tool 1202 and a top view ofmediator 1206, respectively, according to embodiments of the present invention.Skin treatment tool 1200 may comprisegel container 1202 comprisinggel passage 1222 at one end.Tool 1200 may further comprise gel cap/adaptor 1204 adapted to receive gel container orcompartment 1202, for example by snap-on or thread connecting means.Gel cap 1204 comprises alsogel passage 1223 adapted to receive flow of gel fromgel container 1202 throughinput passage 1224 and is made so that itsoutput passage 1226 is located off-center ofcap 1204, so that whenmediator 1206 is rotated with respect to cap 1204 one ofseveral holes 1230 made inmid-partition 1206A, each having different diameter, may be placed, one at a time, againstoutput end passage 1226 of gel, thus providing control means of the rate of flow of gel towardsmediator 1206.Mediator 1206 may further comprisetablet compartment 1207 formed to comprise treatment tablets according to embodiments of the present invention.Tablet compartment 1207 may be capped bytablet cap 1208 adapted to connect ontomediator 1206 so as to closetablet compartment 1207 and contain a tablet in there.Tablet cap 1208 may comprisegel outlet hole 1208A, made to allow flow of gel out side oftool 1200. As shown inFIG. 12B mediator 1206 may have made in itsmid-partition 1206A several holes (or gel passages) 1230A, 1230B, etc., each having different diameter to provide different gel flow capacity.Mid-partition 1206A may also comprise blockedpassage location 1230C to allow inactive mode oftool 1200. It would be apparent to one skilled in the art that mid-partition 1206A may comprise more than two holes with different diameters. It would also be apparent to a person skilled in the art that other means of controlling the rate of flow of gel may be employed without departing from the scope of embodiments of the present invention. - It should be understood that the above description is merely exemplary and that there are various embodiments of the present invention that may be devised, and that the features described in the above-described embodiments, and those not described herein, may be used separately or in any suitable combination, and the invention can be devised in accordance with embodiments not necessarily described above.
Claims (20)
1. An apparatus comprising:
a first compartment to contain a first active material;
a second compartment to contain a second active material; and
a passage to controllably allow said first active material and said second active material to combine thereby to activate a chemical reaction;
wherein the pH of said first active material is higher than 7 and the pH of said second active material is lower than 7, and
wherein said chemical reaction to create effervescent effect.
2. The apparatus of claim 1 , wherein said first active material contains granules.
3. The apparatus of claim 2 , wherein the size of said granules lowers during said chemical reaction.
4. The apparatus of claim 1 wherein said effervescent effect to release carbon dioxide (CO2) gas during said chemical reaction.
5. The apparatus of claim 1 wherein said first active material is in solid phase and said second active material is in liquid phase before said chemical reaction takes place.
6. The apparatus of claim 1 wherein said second compartment is squeezable.
7. The apparatus of claim 1 wherein said passage is in the form of at least one of hole and channel.
8. The apparatus of claim 5 wherein said first active material is formed as a tablet having two main facets substantially parallel to each other.
9. The apparatus of claim 8 wherein said first compartment is adapted to receive said tablet so that a first facet of the tablet is facing away from said second compartment.
10. The apparatus of claim 9 wherein said second active material is to be applied to said tablet to create a chemical reaction on said first facet of said tablet.
11. A method comprising:
providing an apparatus for applying cosmetic treatment;
providing a first active material enclosed in said apparatus;
providing a second active material enclosed in said apparatus;
allowing said second active material to controllably chemically react with said first active material thereby creating an effervescent effect;
using at least one of said first material, said second material, said effervescent effect and materials resulting from said reaction for cosmetic care by rubbing them onto a treated skin.
12. The method of claim 11 further comprising:
providing a liquid to serve as a gliding material between said apparatus and a treated skin.
13. The method of claim 12 wherein said liquid is one or more of a group comprising water and gel.
14. The method of claim 11 , wherein the pH of said first active material is higher than 7 and the pH of said second active material is lower than 7.
15. The method of claim 11 , wherein said first active material contains granules.
16. The apparatus of claim 15 , wherein the size of said granules lowers during said chemical reaction.
17. The method of claim 11 , wherein said effervescent effect to release carbon dioxide (CO2) gas during said chemical reaction
18. The method of claim 11 , wherein said first active material is formed as a solid tablet having two main facets substantially parallel to each other.
19. The method of claim 18 , wherein a first facet of said tablet to face said treated skin.
20. The method of claim 15 , wherein said granules are urged towards said treated skin by said effervescent effect.
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/171,713 US20120283668A1 (en) | 2011-05-04 | 2011-06-29 | Apparatus and method for using effervescent tablets for cosmetic care |
| JP2012105344A JP2012254285A (en) | 2011-05-04 | 2012-05-02 | Effervescent tablet for cosmetic care |
| BR102012010395A BR102012010395A2 (en) | 2011-05-04 | 2012-05-02 | apparatus and method for use of effervescent cosmetic care tablets |
| EP12166531.9A EP2609830A1 (en) | 2011-05-04 | 2012-05-03 | Apparatus and method for using effervescent tablets for cosmetic care |
| IL219589A IL219589A0 (en) | 2011-05-04 | 2012-05-03 | Apparatus and method for using effervescent tablets for cosmetic care |
| RU2012117979/12A RU2012117979A (en) | 2011-05-04 | 2012-05-03 | DEVICE AND METHOD FOR USE EFFICIENT TABLETS FOR COSMETIC CARE |
| CA2776378A CA2776378A1 (en) | 2011-05-04 | 2012-05-03 | Apparatus and method for using effervescent tablets for cosmetic care |
| CN2012101427908A CN102764478A (en) | 2011-05-04 | 2012-05-04 | Apparatus and method for using effervescent tablets for cosmetic care |
| US14/644,325 US20150182426A1 (en) | 2011-05-04 | 2015-03-11 | Apparatus and method for using effervescent tablets for cosmetic care |
| US15/279,510 US20170014323A1 (en) | 2011-05-04 | 2016-09-29 | Apparatus and method for using effervescent tablets for cosmetic care |
| US15/590,236 US9949548B2 (en) | 2011-05-04 | 2017-05-09 | Apparatus and method for using effervescent tablets for cosmetic care |
| US15/925,504 US10251460B2 (en) | 2011-05-04 | 2018-03-19 | Apparatus and method for using effervescent tablets for cosmetic care |
| US16/282,191 US20190328106A1 (en) | 2011-05-04 | 2019-02-21 | Apparatus and method for using effervescent tablets for cosmetic care |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161482302P | 2011-05-04 | 2011-05-04 | |
| US13/171,713 US20120283668A1 (en) | 2011-05-04 | 2011-06-29 | Apparatus and method for using effervescent tablets for cosmetic care |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US14/644,325 Continuation US20150182426A1 (en) | 2011-05-04 | 2015-03-11 | Apparatus and method for using effervescent tablets for cosmetic care |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20120283668A1 true US20120283668A1 (en) | 2012-11-08 |
Family
ID=47090723
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/171,713 Abandoned US20120283668A1 (en) | 2011-05-04 | 2011-06-29 | Apparatus and method for using effervescent tablets for cosmetic care |
| US14/644,325 Abandoned US20150182426A1 (en) | 2011-05-04 | 2015-03-11 | Apparatus and method for using effervescent tablets for cosmetic care |
| US15/279,510 Abandoned US20170014323A1 (en) | 2011-05-04 | 2016-09-29 | Apparatus and method for using effervescent tablets for cosmetic care |
| US15/590,236 Active US9949548B2 (en) | 2011-05-04 | 2017-05-09 | Apparatus and method for using effervescent tablets for cosmetic care |
| US15/925,504 Active US10251460B2 (en) | 2011-05-04 | 2018-03-19 | Apparatus and method for using effervescent tablets for cosmetic care |
| US16/282,191 Abandoned US20190328106A1 (en) | 2011-05-04 | 2019-02-21 | Apparatus and method for using effervescent tablets for cosmetic care |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US14/644,325 Abandoned US20150182426A1 (en) | 2011-05-04 | 2015-03-11 | Apparatus and method for using effervescent tablets for cosmetic care |
| US15/279,510 Abandoned US20170014323A1 (en) | 2011-05-04 | 2016-09-29 | Apparatus and method for using effervescent tablets for cosmetic care |
| US15/590,236 Active US9949548B2 (en) | 2011-05-04 | 2017-05-09 | Apparatus and method for using effervescent tablets for cosmetic care |
| US15/925,504 Active US10251460B2 (en) | 2011-05-04 | 2018-03-19 | Apparatus and method for using effervescent tablets for cosmetic care |
| US16/282,191 Abandoned US20190328106A1 (en) | 2011-05-04 | 2019-02-21 | Apparatus and method for using effervescent tablets for cosmetic care |
Country Status (7)
| Country | Link |
|---|---|
| US (6) | US20120283668A1 (en) |
| EP (1) | EP2609830A1 (en) |
| JP (1) | JP2012254285A (en) |
| CN (1) | CN102764478A (en) |
| BR (1) | BR102012010395A2 (en) |
| CA (1) | CA2776378A1 (en) |
| RU (1) | RU2012117979A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130345648A1 (en) * | 2012-06-22 | 2013-12-26 | Joseph Gavigan Hinden | Insect Bite Itch Stopper |
| US20150153052A1 (en) * | 2012-09-20 | 2015-06-04 | Mitsubishi Electric Corporation | Humidifier and method of hydrophilization processing for humidifying material |
| WO2017001468A1 (en) * | 2015-07-02 | 2017-01-05 | Asamedic As | Two-component composition |
| US10010643B1 (en) | 2017-08-30 | 2018-07-03 | Remarkably Well, Inc | Apparatus for dissolving a fragrance carrier |
| US10085541B2 (en) * | 2014-11-21 | 2018-10-02 | Yolanda Racquel Wells | Nail polish remover in a spray bottle with file attachment |
| US10165906B1 (en) | 2017-08-30 | 2019-01-01 | Remarkably Well, Inc | Apparatus for dissolving a fragrance carrier |
| USD838826S1 (en) | 2017-08-30 | 2019-01-22 | Remarkably Well, Inc | Aromatherapy shower tablet |
| USD848596S1 (en) | 2017-08-30 | 2019-05-14 | Remarkably Well, Inc | Aromatherapy shower tablet dissolver |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201338791A (en) * | 2011-12-19 | 2013-10-01 | Colgate Palmolive Co | Liquid activation system |
| KR102007798B1 (en) * | 2013-05-30 | 2019-08-07 | (주)아모레퍼시픽 | Cosmetic kit containing bubbling tablet and skin water |
| JP2015007017A (en) * | 2013-06-26 | 2015-01-15 | 株式会社東洋新薬 | Foamable skin external preparation |
| JP6552784B2 (en) * | 2013-09-30 | 2019-07-31 | 小林製薬株式会社 | Denture cleaning foam composition |
| JP2015010089A (en) * | 2014-02-06 | 2015-01-19 | 株式会社東洋新薬 | Foamable skin external preparation |
| JP5692618B1 (en) * | 2014-05-12 | 2015-04-01 | 株式会社東洋新薬 | Skin preparation kit |
| CN112451391A (en) * | 2019-09-06 | 2021-03-09 | 深圳市健元医药科技有限公司 | Application of tablet tabletting technology in preparation of cosmetics |
| CN111494283B (en) * | 2020-05-30 | 2020-12-25 | 欧露莲生物科技(广东)有限公司 | Garlic extract composition skin care product containing garlic peptide and preparation process thereof |
| KR102387899B1 (en) * | 2020-06-01 | 2022-04-20 | (주)엠픽 | Skin Peeling Apparatus |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1356544A (en) * | 1918-01-29 | 1920-10-26 | P M Miller Hygienic Specialty | Medicinal effervescing capsule |
| US4665901A (en) * | 1986-03-27 | 1987-05-19 | Donald Spector | Periodontal finger applicator |
| US6467981B1 (en) * | 1998-07-03 | 2002-10-22 | L'oreal | Application for a dispersible substance, an assembly including such an applicator, and a method |
| US7416358B2 (en) * | 2003-04-15 | 2008-08-26 | L'oreal | Applicator intended to be attached to a finger |
| US20100240013A1 (en) * | 2009-03-19 | 2010-09-23 | Levine Jonathan B | Dispenser and applicator that bring reactive substances into contact with each other at time of use |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2312381A (en) * | 1940-10-24 | 1943-03-02 | Frank J Bickenheuser | Medicinal tablet |
| US3367545A (en) * | 1965-09-15 | 1968-02-06 | Products Res & Chemical Corp | Gas-generating dispenser for viscous materials |
| US4487757A (en) * | 1981-12-28 | 1984-12-11 | Colgate-Palmolive Company | Dispensing container of toothpaste which effervesces during toothbrushing |
| US4905825A (en) * | 1989-07-20 | 1990-03-06 | Brader Allen C | Container having lid activated mixing mechanism |
| US4993592A (en) * | 1989-07-20 | 1991-02-19 | Brader Allen C | Method for use of container having lid activated and methods therefor |
| IL105396A (en) * | 1992-04-30 | 1998-02-22 | Takeda Chemical Industries Ltd | Prefilled syringe |
| US5398850A (en) * | 1993-08-06 | 1995-03-21 | River Medical, Inc. | Gas delivery apparatus for infusion |
| US5398851A (en) * | 1993-08-06 | 1995-03-21 | River Medical, Inc. | Liquid delivery device |
| ZA9610374B (en) * | 1995-12-11 | 1997-06-23 | Elan Med Tech | Cartridge-based drug delivery device |
| US6063390A (en) * | 1998-08-07 | 2000-05-16 | Chesebrough-Pond's Usa Co., A Division Of Conopco, Inc. | Cosmetic effervescent cleansing pillow |
| US6754958B2 (en) * | 1998-08-19 | 2004-06-29 | The Gillette Company | Applying fluid preparations to the skin, e.g. in connection with shaving |
| FR2792296B1 (en) * | 1999-04-16 | 2001-06-01 | Oreal | APPLICATOR CAPSULE AND APPLICATION ASSEMBLY PROVIDED WITH SUCH APPLICATOR CAPSULE |
| US6652888B2 (en) | 1999-10-04 | 2003-11-25 | Dermanew, Inc. | Method for skin rejuvenation with buffing cream |
| DE60140657D1 (en) * | 2000-01-17 | 2010-01-14 | Eurand Pharmaceuticals Ltd | OCCUPANCY DISH, EXTRACTOR BATH, BATH ACCESSORY, DETERGENT TABLET, ORAL TABLET |
| US6506713B1 (en) * | 2000-01-31 | 2003-01-14 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Cosmetic effervescent cleansing compositions |
| FR2829116B1 (en) * | 2001-09-04 | 2004-08-27 | Oreal | DEVICE FOR PACKAGING AND APPLYING A PRODUCT, PARTICULARLY COSMETICS |
| US20030064042A1 (en) * | 2001-09-13 | 2003-04-03 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Cosmetic effervescent cleansing pillow |
| KR100456273B1 (en) * | 2001-11-16 | 2004-11-10 | 김용년 | Solid formulation producing carbon dioxide when contacting liquid acid and a method of preparing the same |
| FR2832598B1 (en) * | 2001-11-26 | 2006-01-27 | Oreal | ARTICLE OF PACKAGING AND / OR APPLICATION OF A PRODUCT |
| US20040219124A1 (en) | 2003-05-01 | 2004-11-04 | Gupta Shyam K. | Cosmetic and Pharmaceutical Masks Based on Ion-Pair Delivery System |
| BRPI0411333A (en) * | 2003-06-11 | 2006-07-25 | Procter & Gamble | preparation device for use comprising a preformed hydrogel product |
| US20060128592A1 (en) * | 2004-12-10 | 2006-06-15 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Cosmetic effervescent cleansing pillow with water soluble or dispersible packet |
| FR2880262B1 (en) * | 2005-01-03 | 2013-11-08 | Oreal | COSMETIC OR DERMATOLOGICAL ARTICLE COMPRISING A WATER-SOLUBLE SUPPORT |
| GB0515492D0 (en) * | 2005-07-28 | 2005-08-31 | Reckitt Benckiser Healthcare | Improvements in or relating to compositions,articles and methods |
| US7959369B2 (en) * | 2005-12-09 | 2011-06-14 | L'oreal | Cosmetic or dermatological treatment method and devices for application of such a method |
| HUP0600765A2 (en) * | 2006-10-06 | 2008-10-28 | Istvan Piller | Container for stable carbondioxide foam, process for producing stable carbondioxide foam and method for using of foam |
| US20080146487A1 (en) | 2006-12-13 | 2008-06-19 | O'connor Amanda L | Multiphase bathing tablets |
| US8684968B2 (en) * | 2006-12-29 | 2014-04-01 | Aktivpak, Inc. | Hypodermic drug delivery reservoir and apparatus |
| US20080241200A1 (en) * | 2007-03-30 | 2008-10-02 | Marcy Elizabeth Sojka | Cosmetic skin care system |
| US20110180445A1 (en) * | 2008-06-03 | 2011-07-28 | Marni Markell Hurwitz | Cosmetic tablets and capsules for direct delivery of active ingredients |
| WO2010017361A1 (en) * | 2008-08-07 | 2010-02-11 | Phyzz, Inc. | Effervescent tablets/granules |
| WO2010020772A2 (en) * | 2008-08-22 | 2010-02-25 | Reckitt Benckiser Healthcare (Uk) Limited | Improvements in or relating to compositions |
| WO2010098765A1 (en) * | 2009-02-27 | 2010-09-02 | Leslie Cifuentes French | Dispenser and applicator that bring reactive substances into contact with each other at the time of use |
| JP2009196714A (en) * | 2009-04-16 | 2009-09-03 | Neochemir Inc | Package |
| US9074267B2 (en) * | 2009-07-22 | 2015-07-07 | The Hong Kong Polytechnic University | Rapid fabrication of porous metal-based biomaterial by microwave sintering |
-
2011
- 2011-06-29 US US13/171,713 patent/US20120283668A1/en not_active Abandoned
-
2012
- 2012-05-02 JP JP2012105344A patent/JP2012254285A/en active Pending
- 2012-05-02 BR BR102012010395A patent/BR102012010395A2/en not_active IP Right Cessation
- 2012-05-03 CA CA2776378A patent/CA2776378A1/en not_active Abandoned
- 2012-05-03 EP EP12166531.9A patent/EP2609830A1/en not_active Withdrawn
- 2012-05-03 RU RU2012117979/12A patent/RU2012117979A/en not_active Application Discontinuation
- 2012-05-04 CN CN2012101427908A patent/CN102764478A/en active Pending
-
2015
- 2015-03-11 US US14/644,325 patent/US20150182426A1/en not_active Abandoned
-
2016
- 2016-09-29 US US15/279,510 patent/US20170014323A1/en not_active Abandoned
-
2017
- 2017-05-09 US US15/590,236 patent/US9949548B2/en active Active
-
2018
- 2018-03-19 US US15/925,504 patent/US10251460B2/en active Active
-
2019
- 2019-02-21 US US16/282,191 patent/US20190328106A1/en not_active Abandoned
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1356544A (en) * | 1918-01-29 | 1920-10-26 | P M Miller Hygienic Specialty | Medicinal effervescing capsule |
| US4665901A (en) * | 1986-03-27 | 1987-05-19 | Donald Spector | Periodontal finger applicator |
| US6467981B1 (en) * | 1998-07-03 | 2002-10-22 | L'oreal | Application for a dispersible substance, an assembly including such an applicator, and a method |
| US7416358B2 (en) * | 2003-04-15 | 2008-08-26 | L'oreal | Applicator intended to be attached to a finger |
| US20100240013A1 (en) * | 2009-03-19 | 2010-09-23 | Levine Jonathan B | Dispenser and applicator that bring reactive substances into contact with each other at time of use |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130345648A1 (en) * | 2012-06-22 | 2013-12-26 | Joseph Gavigan Hinden | Insect Bite Itch Stopper |
| US9526881B2 (en) * | 2012-06-22 | 2016-12-27 | X Tech, LLC | Insect bite itch stopper |
| US20150153052A1 (en) * | 2012-09-20 | 2015-06-04 | Mitsubishi Electric Corporation | Humidifier and method of hydrophilization processing for humidifying material |
| US9845961B2 (en) * | 2012-09-20 | 2017-12-19 | Mitsubishi Electric Corporation | Humidifier and method of hydrophilization processing for humidifying material |
| US10085541B2 (en) * | 2014-11-21 | 2018-10-02 | Yolanda Racquel Wells | Nail polish remover in a spray bottle with file attachment |
| WO2017001468A1 (en) * | 2015-07-02 | 2017-01-05 | Asamedic As | Two-component composition |
| US10010643B1 (en) | 2017-08-30 | 2018-07-03 | Remarkably Well, Inc | Apparatus for dissolving a fragrance carrier |
| US10165906B1 (en) | 2017-08-30 | 2019-01-01 | Remarkably Well, Inc | Apparatus for dissolving a fragrance carrier |
| USD838826S1 (en) | 2017-08-30 | 2019-01-22 | Remarkably Well, Inc | Aromatherapy shower tablet |
| USD848596S1 (en) | 2017-08-30 | 2019-05-14 | Remarkably Well, Inc | Aromatherapy shower tablet dissolver |
Also Published As
| Publication number | Publication date |
|---|---|
| US20170014323A1 (en) | 2017-01-19 |
| US20150182426A1 (en) | 2015-07-02 |
| US20190328106A1 (en) | 2019-10-31 |
| US10251460B2 (en) | 2019-04-09 |
| US20170238674A1 (en) | 2017-08-24 |
| US20180271253A1 (en) | 2018-09-27 |
| US9949548B2 (en) | 2018-04-24 |
| CA2776378A1 (en) | 2012-11-04 |
| BR102012010395A2 (en) | 2016-08-02 |
| RU2012117979A (en) | 2013-11-10 |
| JP2012254285A (en) | 2012-12-27 |
| CN102764478A (en) | 2012-11-07 |
| EP2609830A1 (en) | 2013-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10251460B2 (en) | Apparatus and method for using effervescent tablets for cosmetic care | |
| US7879359B2 (en) | Compositions for preparing external carbon dioxide agents | |
| US20090118684A1 (en) | Thermal personal care systems and methods | |
| EP1759688A1 (en) | Cosmetic method for the care of greasy skin and kit therefor | |
| JP7483331B2 (en) | Compositions and methods for treating skin conditions using light and glucosamine hydrochloride | |
| JP2022000465A (en) | Foamable skin external preparation | |
| JP7137337B2 (en) | skin cleanser composition | |
| JP2011088930A (en) | Carbon dioxide percutaneous and transmucosal absorption composition | |
| WO2015037006A1 (en) | Apparatus and method for hair removal and skin exfoliation | |
| JP5643872B2 (en) | Carbon dioxide transdermal / mucosal absorption composition | |
| AU2016208423A1 (en) | Apparatus and method for using effervescent tablets for cosmetic care | |
| KR20120107864A (en) | Composition used for treating skin diseases, preparation comprising said composition and production method therefor | |
| HK1186936A (en) | Apparatus and method for using effervescent tablets for cosmetic care | |
| EP2268257A2 (en) | Compositions based on polymer/hydrogen peroxide complexes and uses thereof | |
| JP5164438B2 (en) | Carbon dioxide transdermal / mucosal absorption composition | |
| JP5699184B2 (en) | Carbon dioxide transdermal / mucosal absorption composition | |
| KR20120125181A (en) | Apparatus and method for using effervescent tablets for cosmetic care | |
| JP2015214537A (en) | Effervescent skin external preparation | |
| JPH05228218A (en) | Caring article | |
| JP5993336B2 (en) | Carbon dioxide transdermal / mucosal absorption composition | |
| RU2793250C2 (en) | Composition and methods for treatment of skin pathological conditions, using light and glucosamine hydrochloride | |
| JP2024507612A (en) | Composition for exfoliating dead skin or improving skin condition | |
| BR102019013368B1 (en) | TOPICAL COMPOSITION COMPRISING GLUCOSAMINE HYDROCHLORIDE, METHODS FOR TREATING THE SKIN AND FOR INCREASING THE PRODUCTION OF HYALURONIC ACID BY THE SKIN USING LIGHT AND GLUCOSAMINE HYDROCHLORIDE AND FILM | |
| JPH1147219A (en) | Bath agent for skin application and bath agent kit for skin application | |
| JP2013177461A (en) | Composition for percutaneously and transmucosally absorbing carbon dioxide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: POLLOGEN LTD., ISRAEL Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SHALEV, PINCHAS;REEL/FRAME:026603/0123 Effective date: 20110628 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |

